Literature DB >> 29073066

Molecular basis for unique specificity of human TRAF4 for platelets GPIbβ and GPVI.

Chang Min Kim1,2, Young-Jin Son3, Sunghwan Kim3, Seo Yun Kim4, Hyun Ho Park5,2.   

Abstract

Tumor necrosis factor (TNF)-receptor associated factor 4 (TRAF4), an adaptor protein with E3-ligase activity, is involved in embryogenesis, cancer initiation and progression, and platelet receptor (GPIb-IX-V complex and GPVI)-mediated signaling for reactive oxygen species (ROS) production that initiates thrombosis at arterial shears. Disruption of platelet receptors and the TRAF4 interaction is a potential target for therapeutic intervention by antithrombotic drugs. Here, we report a crystal structure of TRAF4 (amino acid residues 290∼470) in complex with a peptide from the GPIbβ receptor (amino acid residues 177∼181). The GPIbβ peptide binds to a unique shallow surface composed of two hydrophobic pockets on TRAF4. Further studies revealed the TRAF4-binding motif Arg-Leu-X-Ala. The TRAF4-binding motif was present not only in platelet receptors but also in the TGF-β receptor. The current structure will provide a template for furthering our understanding of the receptor-binding specificity of TRAF4, TRAF4-mediated signaling, and related diseases. Published under the PNAS license.

Entities:  

Keywords:  TRAF domain; TRAF4; glycoprotein Ib; platelet; protein structure

Mesh:

Substances:

Year:  2017        PMID: 29073066      PMCID: PMC5664521          DOI: 10.1073/pnas.1708688114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  LMP1 protein from the Epstein-Barr virus is a structural CD40 decoy in B lymphocytes for binding to TRAF3.

Authors:  ShuangDing Wu; Ping Xie; Kate Welsh; Chenglong Li; Chao-Zhou Ni; Xiuwen Zhu; John C Reed; Arnold C Satterthwait; Gail A Bishop; Kathryn R Ely
Journal:  J Biol Chem       Date:  2005-07-11       Impact factor: 5.157

2.  Structural basis for self-association and receptor recognition of human TRAF2.

Authors:  Y C Park; V Burkitt; A R Villa; L Tong; H Wu
Journal:  Nature       Date:  1999-04-08       Impact factor: 49.962

3.  Tumor necrosis factor receptor associated factor 4 (TRAF4) expression pattern during mouse development.

Authors:  R Masson; C H Régnier; M P Chenard; C Wendling; M G Mattei; C Tomasetto; M C Rio
Journal:  Mech Dev       Date:  1998-02       Impact factor: 1.882

4.  TNF receptor-associated factor 4 (TRAF4) is a novel binding partner of glycoprotein Ib and glycoprotein VI in human platelets.

Authors:  J F Arthur; Y Shen; E E Gardiner; L Coleman; D Murphy; D Kenny; R K Andrews; M C Berndt
Journal:  J Thromb Haemost       Date:  2011-01       Impact factor: 5.824

5.  Single amino acid substitutions confer the antiviral activity of the TRAF3 adaptor protein onto TRAF5.

Authors:  Peng Zhang; Anna Reichardt; Huanhuan Liang; Roghiyh Aliyari; David Cheng; Yaya Wang; Feng Xu; Genhong Cheng; Yingfang Liu
Journal:  Sci Signal       Date:  2012-11-13       Impact factor: 8.192

6.  Structural biology study of human TNF receptor associated factor 4 TRAF domain.

Authors:  Fengfeng Niu; Heng Ru; Wei Ding; Songying Ouyang; Zhi-Jie Liu
Journal:  Protein Cell       Date:  2013-08-27       Impact factor: 14.870

7.  Specific synergy of multiple substrate-receptor interactions in platelet thrombus formation under flow.

Authors:  B Savage; F Almus-Jacobs; Z M Ruggeri
Journal:  Cell       Date:  1998-09-04       Impact factor: 41.582

Review 8.  Potential new targets for antithrombotic therapy.

Authors:  A Gruber; S R Hanson
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

9.  Molecular basis for CD40 signaling mediated by TRAF3.

Authors:  C Z Ni; K Welsh; E Leo; C K Chiou; H Wu; J C Reed; K R Ely
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 10.  All TRAFs are not created equal: common and distinct molecular mechanisms of TRAF-mediated signal transduction.

Authors:  Jee Y Chung; Young Chul Park; Hong Ye; Hao Wu
Journal:  J Cell Sci       Date:  2002-02-15       Impact factor: 5.285

View more
  7 in total

Review 1.  Signaling mechanisms of the platelet glycoprotein Ib-IX complex.

Authors:  Yaping Zhang; Samuel M Ehrlich; Cheng Zhu; Xiaoping Du
Journal:  Platelets       Date:  2022-05-26       Impact factor: 4.236

2.  TRAF4 binds to the juxtamembrane region of EGFR directly and promotes kinase activation.

Authors:  Gang Cai; Liang Zhu; Xing Chen; Kevin Sun; Caini Liu; Ganes C Sen; George R Stark; Jun Qin; Xiaoxia Li
Journal:  Proc Natl Acad Sci U S A       Date:  2018-10-23       Impact factor: 11.205

Review 3.  Structural feature of TRAFs, their related human diseases and therapeutic intervention.

Authors:  Hyun Ho Park
Journal:  Arch Pharm Res       Date:  2021-05-10       Impact factor: 4.946

4.  In Vitro Inhibitory Mechanism Effect of TRAIP on the Function of TRAF2 Revealed by Characterization of Interaction Domains.

Authors:  Eijaz Ahmed Bhat; Chang Min Kim; Sunghwan Kim; Hyun Ho Park
Journal:  Int J Mol Sci       Date:  2018-08-20       Impact factor: 5.923

Review 5.  Structure of TRAF Family: Current Understanding of Receptor Recognition.

Authors:  Hyun H Park
Journal:  Front Immunol       Date:  2018-08-30       Impact factor: 7.561

6.  Comparison of Target Recognition by TRAF1 and TRAF2.

Authors:  Chang Min Kim; Hyun Ho Park
Journal:  Int J Mol Sci       Date:  2020-04-21       Impact factor: 5.923

7.  TNF receptor agonists induce distinct receptor clusters to mediate differential agonistic activity.

Authors:  Xiaojie Yu; Sonya James; James H Felce; Blanka Kellermayer; David A Johnston; H T Claude Chan; Christine A Penfold; Jinny Kim; Tatyana Inzhelevskaya; C Ian Mockridge; Yasunori Watanabe; Max Crispin; Ruth R French; Patrick J Duriez; Leon R Douglas; Martin J Glennie; Mark S Cragg
Journal:  Commun Biol       Date:  2021-06-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.